Purpose/ Objective
What is the current state/problem in practice? No definite evidence found in myocardium of patients with liver cirrhosis.
What is the ideal state/ if the problem is gone? Early myocardial changes in patients with liver cirrhosis (usually referred to as cirrhotic cardiomyopathy) can be diagnosed.
Following this activity, learners will:
- Understand structural and functional changes in myocardium observed in cardiac magnetic resonance and echocardiography
- Understand why myocardial structural and functional changes take place in patients with liver cirrhosis (i.e. pathophysiology)
Accreditation Statement
The Society for Cardiovascular Magnetic Resonance (SCMR) is accredited by the Accreditation Council for Continuing Medical Education (ACCME) to provide continuing medical education for physicians.
Credit Designation Statement
The Society for Cardiovascular Magnetic Resonance (SCMR) designates this Journal-based CME activity for a maximum of 1.0 AMA PRA Category 1 Credit (s)™. Physicians should claim only the credit commensurate with the extent of their participation in the activity.
This CME activity was designed to improve understanding myocardial changes in patients with liver cirrhosis awaiting liver transplantation and intended to highlight what changes can be observed in cirrhotic cardiomyopathy.
Instructions for Claiming CME
- Attend the sessions in full for which credit is sought
- Complete the post-activity evaluation
- A certificate of completion will be available once the evaluation is submitted
Financial Disclosures
This study was supported by the grant of CJ healthcare 2016 research fund. CJ HealthCare is a South Korean Medicine and Biotechnology company based in Seoul that manufactures synthetic medicines, general medicines, and Health drinks.
Disclosure of Commercial Support
SCMR received funding to support this activity from the following organizations:
Bibliography
Please see the bibliography at the end of the journal article.
1) Kim HM, Kim HK, Lee JH et al. Myocardial Structural and Functional Changes in Patients with Liver Cirrhosis Awaiting Liver Transplantation ; A Comprehensive Cardiac Magnetic Resonance and Echocardiography Study . JCMR 2020. In press
2) Unseth JH, Olmstead EG, Abboud F. A study of heart disease in one hundred eight hospitalized patients dying with portal cirrhosis. AMA Arch Intern Med. 1958;102(3):405-13
3) Moller S, Bernardi M. Interactions of the heart and the liver. Eur Heart J. 2013;34(36):2804-11.